Literature DB >> 19288089

Migraine: where and how does the pain originate?

Karl Messlinger1.   

Abstract

Migraine is a complex neurological disease with a genetic background. Headache is the most prominent and clinically important symptom of migraine but its origin is still enigmatic. Numerous clinical, histochemical, electrophysiological, molecular and genetical approaches form a puzzle of findings that slowly takes shape. The generation of primary headaches like migraine pain seems to be the consequence of multiple pathophysiological changes in meningeal tissues, the trigeminal ganglion, trigeminal brainstem nuclei and descending inhibitory systems, based on specific characteristics of the trigeminovascular system. This contribution reviews the current discussion of where and how the migraine pain may originate and outlines the experimental work to answer these questions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288089     DOI: 10.1007/s00221-009-1756-y

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  192 in total

1.  Convergence of meningeal and facial afferents onto trigeminal brainstem neurons: an electrophysiological study in rat and man.

Authors:  J Ellrich; O K Andersen; K Messlinger; L Arendt-Nielsen
Journal:  Pain       Date:  1999-09       Impact factor: 6.961

2.  Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation.

Authors:  Karen D Davis; Jonathan O Dostrovsky
Journal:  Pain       Date:  1986-06       Impact factor: 6.961

3.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

4.  The central projections of trigeminal primary afferent neurons in the cat as determined by the tranganglionic transport of horseradish peroxidase.

Authors:  C F Marfurt
Journal:  J Comp Neurol       Date:  1981-12-20       Impact factor: 3.215

5.  A nosographic analysis of the migraine aura in a general population.

Authors:  M B Russell; J Olesen
Journal:  Brain       Date:  1996-04       Impact factor: 13.501

6.  Cerebrovascular application of bradykinin excites central sensory neurons.

Authors:  K D Davis; J O Dostrovsky
Journal:  Brain Res       Date:  1988-04-19       Impact factor: 3.252

7.  Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus.

Authors:  S Koulchitsky; M J M Fischer; K Messlinger
Journal:  Cephalalgia       Date:  2008-11-25       Impact factor: 6.292

8.  Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine.

Authors:  T W Ho; L K Mannix; X Fan; C Assaid; C Furtek; C J Jones; C R Lines; A M Rapoport
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

9.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 10.  Migraine: a complex genetic disorder.

Authors:  Maija Wessman; Gisela M Terwindt; Mari A Kaunisto; Aarno Palotie; Roel A Ophoff
Journal:  Lancet Neurol       Date:  2007-06       Impact factor: 44.182

View more
  51 in total

1.  Local action of the proinflammatory cytokines IL-1β and IL-6 on intracranial meningeal nociceptors.

Authors:  Xichun Zhang; Rami Burstein; Dan Levy
Journal:  Cephalalgia       Date:  2011-12-05       Impact factor: 6.292

Review 2.  Identification of molecular genetic factors that influence migraine.

Authors:  Bridget H Maher; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2011-04-26       Impact factor: 3.291

3.  Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.

Authors:  Jun Zhao; Dan Levy
Journal:  J Neurosci       Date:  2018-04-27       Impact factor: 6.167

4.  CGRP receptor activity in mice with global expression of human receptor activity modifying protein 1.

Authors:  Keegan J Bohn; Baolin Li; Xiaofang Huang; Bianca N Mason; Anne-Sophie Wattiez; Adisa Kuburas; Christopher S Walker; Peiyi Yang; Jianliang Yu; Beverly A Heinz; Kirk W Johnson; Andrew F Russo
Journal:  Br J Pharmacol       Date:  2017-04-22       Impact factor: 8.739

Review 5.  Where does a migraine attack originate? In the brainstem.

Authors:  J Tajti; D Szok; Á Párdutz; B Tuka; A Csáti; A Kuris; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

Review 6.  CGRP as a neuropeptide in migraine: lessons from mice.

Authors:  Andrew F Russo
Journal:  Br J Clin Pharmacol       Date:  2015-07-14       Impact factor: 4.335

Review 7.  Calcitonin gene-related peptide (CGRP): a new target for migraine.

Authors:  Andrew F Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014-10-08       Impact factor: 13.820

Review 8.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

9.  Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.

Authors:  XiChun Zhang; Vanessa Kainz; Jun Zhao; Andrew M Strassman; Dan Levy
Journal:  Ann Neurol       Date:  2013-06-17       Impact factor: 10.422

10.  Stimulation of Posterior Thalamic Nuclei Induces Photophobic Behavior in Mice.

Authors:  Levi P Sowers; Mengya Wang; Brandon J Rea; Rebecca J Taugher; Adisa Kuburas; Youngcho Kim; John A Wemmie; Christopher S Walker; Debbie L Hay; Andrew F Russo
Journal:  Headache       Date:  2020-08-04       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.